Literature DB >> 4063134

DNA index of ovarian carcinomas from 56 patients: in vivo in vitro studies.

E Erba, M Vaghi, S Pepe, G Amato, M Bistolfi, P Ubezio, C Mangioni, F Landoni, L Morasca.   

Abstract

Out of 130 ovarian cancer patients the DNA index of cells from ovarian carcinoma was studied in 56 cases in which cytospin preparations showed the presence of atypical cells. In 24 patients the population had a diploid DNA index (1.0) and in the others the DNA index ranged from 1.2 to 2.0 (tetraploid). No hypodiploid or hypertetraploid populations were detected. Repeated samples from the same patients did not show any significant differences and primary culture did not alter the DNA index. In contrast, cell cycle phase distribution differed greatly from sample to sample, as also the ratio between DNA diploid and DNA aneuploid populations. Primary culture was successful in 57% of the tumours, with a higher percentage of success in DNA aneuploid tumours. After primary culture the ratio between DNA aneuploid cells and DNA diploid cells increased. In relation to the histological gradings of malignancy, DNA aneuploid cells clustered in the highest grade of malignancy. The mean S-phase for tumours with a DNA index of 1.0 was 3.5 and 14.1% for those with DNA index greater than 1. Ovarian carcinomas show a large difference in DNA index between patients even after primary culture.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4063134      PMCID: PMC1977253          DOI: 10.1038/bjc.1985.228

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  26 in total

1.  Staging, grading and histochemistry of ovarian epithelial tumors.

Authors:  M E Long; S C Sommers
Journal:  Clin Obstet Gynecol       Date:  1969-12       Impact factor: 2.190

2.  Determination of ploidy and proliferative characteristics of human solid tumors by pulse cytophotometry.

Authors:  B Barlogie; W Göhde; D A Johnston; L Smallwood; J Schumann; B Drewinko; E J Freireich
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

3.  Cellular DNA content as a marker of neoplasia in man.

Authors:  B Barlogie; B Drewinko; J Schumann; W Göhde; G Dosik; J Latreille; D A Johnston; E J Freireich
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

4.  Advanced ovarian cancer: correlation of histologic grade with response to therapy and survival.

Authors:  R F Ozols; A J Garvin; J Costa; R M Simon; R C Young
Journal:  Cancer       Date:  1980-02       Impact factor: 6.860

5.  Flow cytometric analysis of DNA content for ploidy determination in human solid tumors.

Authors:  B Barlogie; W Göhde; B Drewinko
Journal:  J Histochem Cytochem       Date:  1979-01       Impact factor: 2.479

6.  Effects on in vitro tumor growth of macrophages isolated from human ascitic ovarian tumors.

Authors:  A Mantovani; G Peri; N Polentarutti; G Bolis; C Mangioni; F Spreafico
Journal:  Int J Cancer       Date:  1979-02       Impact factor: 7.396

Review 7.  Clinical application of flow cytometry: a review.

Authors:  O D Laerum; T Farsund
Journal:  Cytometry       Date:  1981-07

8.  Cellular DNA content--a stable feature in epithelial ovarian cancer.

Authors:  M L Friedlander; I W Taylor; P Russell; M H Tattersall
Journal:  Br J Cancer       Date:  1984-02       Impact factor: 7.640

9.  In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.

Authors:  A P Wilson; F E Neal
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640

10.  Prognostic significance of modal DNA value and other factors in malignant tumours, based on 1465 cases.

Authors:  N B Atkin; R Kay
Journal:  Br J Cancer       Date:  1979-08       Impact factor: 7.640

View more
  2 in total

1.  Flow cytometric analysis of DNA content in human ovarian cancers.

Authors:  E Erba; P Ubezio; S Pepe; M Vaghi; S Marsoni; W Torri; C Mangioni; F Landoni; M D'Incalci
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640

2.  Mitozolomide activity on human cancer cells in vitro.

Authors:  E Erba; S Pepe; P Ubezio; A Lorico; L Morasca; C Mangioni; F Landoni; M D'Incalci
Journal:  Br J Cancer       Date:  1986-12       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.